Vaccination with amyloid-β peptide induces autoimmune encephalomyelitis in C57/BL6 mice

Brain

Volumn 126, Issue 2, 2003, Pages 285-291

  Furlan, Roberto ^a   Brambilla, Elena ^a   Sanvito, Francesca ^a   Roccatagliata, Luca ^b   Olivieri, Stefano ^a   Bergami, Alessandra ^a   Pluchino, Stefano ^a   Uccelli, Antonio ^b   Comi, Giancarlo ^a   Martino, Gianvito ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Alzheimer's disease; Amyloid peptide; Encephalomyelitis; Vaccination

Indexed keywords

AMYLOID BETA PROTEIN; CD4 ANTIGEN; PERTUSSIS TOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENCEPHALOMYELITIS; FEMALE; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NEUROPROTECTION; NONHUMAN; PATHOLOGICAL ANATOMY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; REACTION ANALYSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; VACCINATION;

EID: 0037317234     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg031     Document Type: Article

References (21)

1. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. [Review]. Nature 1996; 383: 787-93.
2. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000; 6: 916-9.
3. Birmingham K, Frantz S. Set back to Alzheimer vaccine studies. Nat Med 2002; 8: 199-200.
4. Brazil MI, Chung H, Maxfield FR. Effects of incorporation of immunoglobulin G and complement component Clq on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J Biol Chem 2000; 275: 16941-7.
5. Cyster JG, Goodnow CC. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 1995; 182: 581-6.
6. Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, et al. Intrathecal delivery of IFN-γprotects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol 2001; 167: 1821-9.
7. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993; 72: 551-60.
8. Goverman J, Brabb T, Paez A, Harrington C, von Dassow P. Initiation and regulation of CNS autoimmunity. [Review]. Crit Rev Immunol 1997; 17: 469-80.
9. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, et al. A β-peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 2000; 408: 979-82.
10. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-6.
11. Linthicum DS, Frelinger JA. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes. J Exp Med 1982; 156: 31-40.
12. Linthicum DS, Munoz JJ, Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol 1982; 73: 299-310.
13. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, et al. A β-peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000; 408: 982-5.
14. Moiola L, Galbiati F, Martino G, Amadio S, Brambilla E, Comi G, et al. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur J Immunol 1998; 28: 2487-97.
15. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995; 182: 1357-67.
16. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999; 400: 173-7.
17. Steiner H, Capell A, Leimer U, Haass C. Genes and mechanisms involved in β-amyloid generation and Alzheimer's disease. [Review]. Eur Arch Psychiatry Clin Neurosci 1999; 249: 266-70.
18. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994; 145: 452-60.
19. Thatte U. AN-1792 (Elan). [Review]. Curr Opin Investig Drugs 2001; 2: 663-7.
20. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380: 168-71.
21. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by Clq. J Immunol 2001; 166: 7496-503.